Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.
作者信息
Clemons Anthony, Vasiadi Magdalini, Kempuraj Duraisamy, Kourelis Taxiarchis, Vandoros Gregory, Theoharides Theoharis C
出版信息
J Clin Psychopharmacol. 2011 Jun;31(3):385-7. doi: 10.1097/JCP.0b013e3182196e50.
Abstract
摘要
相似文献
1
Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.阿米替林和氯丙嗪抑制人肥大细胞释放促炎介质：与慢性疲劳综合征的可能关联。
J Clin Psychopharmacol. 2011 Jun;31(3):385-7. doi: 10.1097/JCP.0b013e3182196e50.
2
Pharmacological regulation of mediator release from human mast cells.人肥大细胞介质释放的药理学调节
Clin Exp Allergy. 1998 Oct;28(10):1171-3. doi: 10.1046/j.1365-2222.1998.00393.x.
3
Non-differential inhibition of histamine and serotonin release from mast cells by amitriptyline.阿米替林对肥大细胞组胺和5-羟色胺释放的非特异性抑制作用。
Agents Actions. 1986 Apr;18(1-2):89-91. doi: 10.1007/BF01987991.
4
The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release.三环类抗精神病药和抗抑郁药的亲脂性与组胺释放之间的关系。
Eur J Pharmacol. 1972 May;18(2):139-47. doi: 10.1016/0014-2999(72)90235-x.
5
The effects of anti-asthma drugs on mediator release from cultured human mast cells.抗哮喘药物对培养的人肥大细胞介质释放的影响。
Clin Exp Allergy. 1998 Oct;28(10):1228-36. doi: 10.1046/j.1365-2222.1998.00394.x.
6
Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo.米替福新在体外和体内均能抑制人肥大细胞的活化及介质释放。
J Invest Dermatol. 2009 Feb;129(2):496-8. doi: 10.1038/jid.2008.248. Epub 2008 Sep 4.
7
The activity of amitriptyline as a differential inhibitor of amine secretion from rat peritoneal mast cells: the contribution of amine uptake.阿米替林作为大鼠腹膜肥大细胞胺分泌差异抑制剂的活性：胺摄取的作用。
Agents Actions. 1990 Apr;30(1-2):41-3. doi: 10.1007/BF01968993.
8
Mercury induces inflammatory mediator release from human mast cells.汞会引起人肥大细胞炎症介质的释放。
J Neuroinflammation. 2010 Mar 11;7:20. doi: 10.1186/1742-2094-7-20.
9
Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome.异黄酮抑制聚肌苷酸胞苷酸（poly(I:C)）诱导的血清、脑和皮肤炎症介质——与慢性疲劳综合征的相关性。
J Neuroinflammation. 2014 Oct 31;11:168. doi: 10.1186/s12974-014-0168-5.
10
Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation.大麻素类似物对肥大细胞介质释放的控制：慢性炎症的新视角
J Neuroendocrinol. 2008 May;20 Suppl 1:20-5. doi: 10.1111/j.1365-2826.2008.01674.x.
引用本文的文献
1
Contact Urticaria and Related Conditions: Clinical Review.接触性荨麻疹及相关病症：临床综述
Contact Dermatitis. 2025 Aug;93(2):87-107. doi: 10.1111/cod.14794. Epub 2025 Apr 2.
2
Amitriptyline Downregulates Chronic Inflammatory Response to Biomaterial in Mice.阿米替林下调小鼠生物材料慢性炎症反应。
Inflammation. 2021 Apr;44(2):580-591. doi: 10.1007/s10753-020-01356-0. Epub 2020 Oct 9.
3
Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?近年来，我们对肥大细胞激活的认识不断深入——或者应该说是肥大细胞介质紊乱？
Expert Rev Clin Immunol. 2019 Jun;15(6):639-656. doi: 10.1080/1744666X.2019.1596800. Epub 2019 Apr 22.
4
Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.慢性疲劳综合征/肌痛性脑脊髓炎的治疗与管理：殊途同归。
Br J Pharmacol. 2017 Mar;174(5):345-369. doi: 10.1111/bph.13702. Epub 2017 Feb 1.
5
Pharmacological treatment options for mast cell activation disease.肥大细胞活化疾病的药物治疗选择
Naunyn Schmiedebergs Arch Pharmacol. 2016 Jul;389(7):671-94. doi: 10.1007/s00210-016-1247-1. Epub 2016 Apr 30.
6
Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism.阿米替林通过依赖于 Trk 的机制防止 TNF-α 诱导的萎缩和突触标记物减少。
Pharmacol Res Perspect. 2016 Mar 8;4(2):e00195. doi: 10.1002/prp2.195. eCollection 2016 Apr.
7
Fibromyalgia syndrome in need of effective treatments.纤维肌痛综合征需要有效的治疗方法。
J Pharmacol Exp Ther. 2015 Nov;355(2):255-63. doi: 10.1124/jpet.115.227298. Epub 2015 Aug 25.
8
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.降钙素基因相关肽在偏头痛中的作用：外周炎症与中枢调节的交集。
Expert Rev Mol Med. 2011 Nov 29;13:e36. doi: 10.1017/S1462399411002067.
本文引用的文献
1
Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.中度运动后症状恶化的严重程度与慢性疲劳综合征中的细胞因子活性有关。
Psychophysiology. 2010 Jul 1;47(4):615-24. doi: 10.1111/j.1469-8986.2010.00978.x. Epub 2010 Mar 4.
2
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.IL-33 增强了 P 物质诱导的人肥大细胞 VEGF 分泌，并在银屑病皮肤中增加。
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4448-53. doi: 10.1073/pnas.1000803107. Epub 2010 Feb 16.
3
Plasma cytokines in women with chronic fatigue syndrome.慢性疲劳综合征女性患者的血浆细胞因子
J Transl Med. 2009 Nov 12;7:96. doi: 10.1186/1479-5876-7-96.
4
Chronic fatigue syndrome: aetiology, diagnosis and treatment.慢性疲劳综合征：病因、诊断与治疗
BMC Psychiatry. 2009 Oct 23;9 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-9-S1-S1.
5
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.慢性疲劳综合征的药物治疗：聚焦抗抑郁药的作用
Expert Opin Pharmacother. 2009 Jul;10(10):1561-70. doi: 10.1517/14656560902988510.
6
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis.抗抑郁药治疗纤维肌痛综合征：一项荟萃分析。
JAMA. 2009 Jan 14;301(2):198-209. doi: 10.1001/jama.2008.944.
7
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants.慢性疲劳综合征、肥大细胞与三环类抗抑郁药
J Clin Psychopharmacol. 2005 Dec;25(6):515-20. doi: 10.1097/01.jcp.0000193483.89260.a7.
8
Mast cells as "tunable" effector and immunoregulatory cells: recent advances.肥大细胞作为“可调谐”效应细胞和免疫调节细胞：最新进展
Annu Rev Immunol. 2005;23:749-86. doi: 10.1146/annurev.immunol.21.120601.141025.
9
Spinal fluid abnormalities in patients with chronic fatigue syndrome.慢性疲劳综合征患者的脑脊液异常
Clin Diagn Lab Immunol. 2005 Jan;12(1):52-5. doi: 10.1128/CDLI.12.1.52-55.2005.
10
Mast cells as targets of corticotropin-releasing factor and related peptides.肥大细胞作为促肾上腺皮质激素释放因子及相关肽的作用靶点。
Trends Pharmacol Sci. 2004 Nov;25(11):563-8. doi: 10.1016/j.tips.2004.09.007.
Zotero 插件